These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cis-platinum in the treatment of testicular and other cancers. Williams SD; Einhorn LH Adv Intern Med; 1982; 27():531-45. PubMed ID: 7041553 [No Abstract] [Full Text] [Related]
4. The role of cis-platinum in solid-tumor therapy. Einhorn LH; Williams SD N Engl J Med; 1979 Feb; 300(6):289-91. PubMed ID: 366407 [No Abstract] [Full Text] [Related]
5. [A new cytostatic agent: cis-dischlorodiamin platinum II (DDP)]. Gallmeier WM; Bruntsch U MMW Munch Med Wochenschr; 1979 May; 121(18):624-7. PubMed ID: 108586 [No Abstract] [Full Text] [Related]
6. Recent updates in the clinical use of platinum compounds for the treatment of lung, breast, and genitourinary tumors and myeloma. Belani CP Semin Oncol; 2004 Dec; 31(6 Suppl 14):25-33. PubMed ID: 15726531 [TBL] [Abstract][Full Text] [Related]
7. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model. Horowitz NS; Hua J; Gibb RK; Mutch DG; Herzog TJ Gynecol Oncol; 2004 Jul; 94(1):67-73. PubMed ID: 15262121 [TBL] [Abstract][Full Text] [Related]
8. [Recurrent and 2nd line therapy in ovarian carcinoma: an overview of conventional systemic therapy modalities]. du Bois A; Lück HJ; Meerpohl HG Zentralbl Gynakol; 1997; 119(7):299-323. PubMed ID: 9340970 [TBL] [Abstract][Full Text] [Related]
9. [The ototoxicity of cisplatin in the chemotherapy of tumors of the head-neck area. Our experience]. Sbalzarini G; Malusardi G; Pandolfi C; Cerri A Minerva Med; 1990 May; 81(5):403-5. PubMed ID: 2377307 [TBL] [Abstract][Full Text] [Related]
10. Medical therapy of advanced malignant epithelial tumours of the ovary. Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983 [TBL] [Abstract][Full Text] [Related]
11. [Chemotherapy of solid tumors. The role of cisplatin in today's chemotherapy]. Kenis Y; Rozencweig M; Sanders C Rev Med Brux; 1983 Apr; 4(4):213-7. PubMed ID: 6683864 [No Abstract] [Full Text] [Related]
12. Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug. Kelland LR; Abel G; McKeage MJ; Jones M; Goddard PM; Valenti M; Murrer BA; Harrap KR Cancer Res; 1993 Jun; 53(11):2581-6. PubMed ID: 8388318 [TBL] [Abstract][Full Text] [Related]
13. [Ototoxicity of cis-diammine glycolato platinum, 254-S]. Horiuchi M; Miyake H; Ota K Gan To Kagaku Ryoho; 1992 Aug; 19(9):1327-32. PubMed ID: 1503488 [TBL] [Abstract][Full Text] [Related]
14. Cisplatin based chemotherapy in testicular cancer patients: long term platinum excretion and clinical effects. Hohnloser JH; Schierl R; Hasford B; Emmerich B Eur J Med Res; 1996 Sep; 1(11):509-14. PubMed ID: 9438151 [TBL] [Abstract][Full Text] [Related]
15. The future role of carboplatin. Ruckdeschel JC Semin Oncol; 1994 Oct; 21(5 Suppl 12):114-8. PubMed ID: 7992063 [TBL] [Abstract][Full Text] [Related]